1. Gellynck E, Heyninck K, Andressen KW, Haegeman G, Levy FO, Vanhoenacker P, et al. The serotonin 5-HT7 receptors: two decades of research. Exp Brain Res. 2013; 230:555–568.
Article
2. Birmes P, Coppin D, Schmitt L, Lauque D. Serotonin syndrome: a brief review. CMAJ. 2003; 168:1439–1442.
3. Boyer EW, Shannon M. The serotonin syndrome. N Engl J Med. 2005; 352:1112–1120.
Article
4. Moellering RC. Linezolid: the first oxazolidinone antimicrobial. Ann Intern Med. 2003; 138:135–142.
Article
5. Wigen CL, Goetz MB. Serotonin syndrome and linezolid. Clin Infect Dis. 2002; 34:1651–1652.
Article
6. Quinn DK, Stern TA. Linezolid and serotonin syndrome. Prim Care Companion J Clin Psychiatry. 2009; 11:353–356.
Article
7. Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, gram-positive infections: experience from a compassionate-use program. Clin Infect Dis. 2003; 36:159–168.
Article
8. Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH. Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest. 2003; 124:1789–1797.
9. Lawrence KR, Adra M, Gillman PK. Serotonin toxicity associated with the use of linezolid: a review of postmarketing data. Clin Infect Dis. 2006; 42:1578–1583.
Article
10. Alisky JM. Can chlorpheniramine cause serotonin syndrome? Singapore Med J. 2006; 47:1014.
11. Savard S, Desmeules S, Riopel J, Agharazii M. Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome. Am J Kidney Dis. 2009; 54:e17–e20.
Article
12. Mills KC. Serotonin syndrome. Am Fam Physician. 1995; 52:1475–1482.
13. Sternbach H. The serotonin syndrome. Am J Psychiatry. 1991; 148:705–713.
Article